Ultragenyx Pharmaceutical Inc.

RARE stock is not Shariah-compliant

Dikuasakan oleh API Zoya

About Ultragenyx Pharmaceutical Inc. (RARE)

Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company that focuses on developing and commercializing novel products for the treatment of rare and ultra-rare genetic diseases. Its product portfolio includes biologic products for the treatment of X-linked hypophosphatemia, Mucopolysaccharidosis VII, long-chain fatty acid oxidation disorders, and homozygous familial hypercholesterolemia. The company has several product candidates in its pipeline for the treatment of various genetic disorders, including glycogen storage diseases, osteogenesis imperfecta, Angelman syndrome, and Wilson disease.

Soalan lazim

Is Ultragenyx Pharmaceutical Inc. (RARE) stock halal to invest in?
Yes, RARE is not Shariah-compliant based on the company’s latest financial reports and therefore considered halal to invest in. Last updated on Aug 27, 2024.
No, RARE is not Shariah-compliant based on the company’s latest financial reports and therefore not considered halal to invest in. Last updated on Aug 27, 2024.
RARE is flagged as not Shariah-compliant in terms of Shariah compliance based on the company's latest financial reports. This means that while the company's operations do not definitively violate Islamic guidelines, there are certain aspects of Ultragenyx Pharmaceutical Inc.'s business that require careful consideration. Last updated on Aug 27, 2024.
Does Ultragenyx Pharmaceutical Inc. have any interest income?
Yes, Ultragenyx Pharmaceutical Inc. does have interest income. According to the company's latest annual report for the fiscal year ending Dec 31, 2023, Ultragenyx Pharmaceutical Inc. reported revenue of 434249000 and interest income of 26688000. The interest income represents 5.79% of the combined total. It's worth noting that some companies may report additional interest income as part of their revenue. For a detailed breakdown of all interest income and revenue segments, please refer to the full Shariah compliance report available in the Zoya app.
No, Ultragenyx Pharmaceutical Inc. has not reported any interest income. According to the company's latest annual report for the fiscal year ending Dec 31, 2023, Ultragenyx Pharmaceutical Inc. reported total revenue of 434249000, with no separate interest income disclosed. However, it's worth noting that some companies may report interest income as part of their revenue. For a detailed breakdown of all interest income and revenue segments, please refer to the full Shariah compliance report available in the Zoya app.
What guidelines are used to determine if Ultragenyx Pharmaceutical Inc. stock is Shariah-compliant?
Kami menggunakan garis panduan yang ditetapkan oleh Organisasi Perakaunan dan Pengauditan untuk Institusi Kewangan Islam (AAOIFI) untuk menilai pematuhan Syariah. AAOIFI ialah organisasi antarabangsa terkemuka yang menetapkan piawaian untuk kewangan Islam. Garis panduan mereka membantu menentukan sama ada aktiviti perniagaan dan struktur kewangan syarikat sejajar dengan prinsip Islam. Piawaian ini dihormati secara meluas dalam industri kewangan Islam dan menyediakan rangka kerja yang konsisten untuk menilai pematuhan Syariah saham dan instrumen kewangan lain. Lembaga Syariah AAOIFI termasuk ulama terkenal seperti Sheikh Muhammad Taqi Usmani, Sheikh AbdulSattar Abu Ghuddah, dan Sheikh Abdullah AlManea.
How often is Ultragenyx Pharmaceutical Inc. stock reviewed for Shariah compliance?
The Shariah compliance status of Ultragenyx Pharmaceutical Inc. stock is reviewed on a regular basis, with a minimum frequency of once per quarter. However, if there are any significant changes or major developments in the company's operations that may impact its compliance, an immediate review will be conducted to ensure ongoing adherence to Shariah principles.
How can I stay updated on Ultragenyx Pharmaceutical Inc.'s compliance status?
To stay informed, we recommend regularly checking Zoya for updates. You can also enable alerts within the Zoya app to receive notifications whenever there is a change in the Shariah compliance of RARE, or any other stocks you are monitoring. This is particularly useful as Shariah compliance can fluctuate due to changes in a company's financial ratios or business activities.
Are dividends from Ultragenyx Pharmaceutical Inc. stock considered halal?
Yes, dividends from RARE are considered halal. However, you may need to purify a portion of the dividend if the company has any impermissible revenue. Shariah standards typically allow up to 5% of revenue from impermissible sources for a stock to remain compliant. To find the exact percentage of impermissible revenue for Ultragenyx Pharmaceutical Inc. (RARE), check the Zoya app. For more details on the purification process, read our comprehensive guide.
No, dividends from RARE are not considered halal because the stock is currently not Shariah-compliant. When a stock is non-compliant, any dividends received from it are considered impermissible income and should be donated to charity as a form of purification. To learn more about the purification process and how to handle impermissible income, read our comprehensive guide.
Do I need to pay Zakat on my Ultragenyx Pharmaceutical Inc. shares?
If you hold Ultragenyx Pharmaceutical Inc. stock as an investment, through an Employee Stock Ownership Plan (ESOP), stock options, restricted stock units (RSUs), or any other form of stock ownership, and meet the Nisab threshold, you may be required to pay Zakat on it. The calculation of Zakat on stocks can be complex and depends on various factors. To help make this easy, we've created a free Zakat calculation tool. For an even easier experience, use the Zoya mobile app, where you can link your brokerage account to automatically import holdings.

How to buy Ultragenyx Pharmaceutical Inc. (RARE) stock on Zoya

  1. Daftar untuk mendapatkan akaun Zoya percuma
    Ia mudah untuk bermula. Anda boleh mendaftar untuk akaun terus di tapak web kami atau dengan memuat turun aplikasi Zoya untuk iOS atau Android.
  2. Pautkan akaun pembrokeran
    Zoya bekerjasama dengan broker terkemuka seperti Alpaca dan lain-lain untuk cara yang lancar untuk membeli dan mengurus saham melalui Zoya.
  3. Tentukan berapa banyak yang perlu dilaburkan
    Navigasi ke skrin carian dan taipkan nama stok ke dalam bar carian. Kemudian, klik butang beli dan masukkan jumlah yang anda ingin laburkan, sama ada dari segi dolar atau bilangan saham. Semak harga saham masa nyata dan anggaran kuantiti saham sebelum mengesahkan pelaburan anda.
  4. Urus portfolio anda di satu tempat
    Anda boleh mencari saham anda yang baru dibeli dalam portfolio Zoya anda bersama-sama pegangan anda yang lain. Dayakan makluman untuk dimaklumkan tentang sebarang perubahan dalam pematuhan Syariah portfolio anda.

Siaran komuniti